Table 4.
The mean and standard deviation of changes in baseline variables after intervention in both groups
| Variable | MEAN ± SD | P value | |
|---|---|---|---|
| Group1: metformin+sitagliptin |
Group2: metformin+pioglitazone |
||
| FBS (mg/dl) | -18.48 ± 33.32 | -20.53 ± 53.97 | 0.773 |
| BS2hpp (mg/dl) | -48.51 ± 57.13 | -31.51 ± 54.20 | 0.05 |
| HbA1c (%) | -1.001 ± 0.83 | -0.75 ± 1.20 | 0.132 |
| BUN (mg/dl) | -0.125 ± 1.88 | -0.10 ± 1.47 | 0.92 |
| Creatinin (mg/dl) | 0.01 ± 0.13 | 0.055 ± 0.80 | 0.66 |
| AST (U/L) | -2.99 ± 14.90 | -0.21 ± 2.29 | 0.105 |
| ALT (U/L) | -2.75 ± 13.02 | -0.34 ± 2.50 | 0.106 |
| TG (mg/dl) | -34.40 ± 52.97 | 0.85 ± 96.60 | 0.005 |
| Chol (mg/dl) | -23.66 ± 39.33 | -4.98 ± 38.39 | 0.003 |
| HDL (mg/dl) | 3.17 ± 9.96 | 0.17 ± 6.99 | 0.029 |
| Weight (kg) | -1.08 ± 2.39 | 0.27 ± 2.42 | <0.001 |
| SBP (mmHg) | -3.50 ± 13.69 | -2.72 ± 12.75 | 0.71 |
| DBP (mmHg) | -2.12 ± 7.41 | -0.75 ± 7.87 | 0.25 |